Skip to the story
All stories

US names India, China, Pakistan on drug transit and production list

Presidential determination for FY2027 designates 23 countries, noting India's efforts while identifying others for failing counternarcotics obligations.

AI-assisted coverage comparison, editor-supervised · How this was made

Published Updated
US names India, China, Pakistan on drug transit and production list

What this story says

  • The US presidential determination for fiscal year 2027 lists India, China, and Pakistan among 23 countries designated as major drug transit or illicit drug-producing nations.
  • Afghanistan, Bolivia, Burma, and Colombia were identified as countries that have failed demonstrably to meet counternarcotics obligations.
  • The determination welcomes Prime Minister Narendra Modi's efforts to address illicit opium poppy cultivation and strengthen supply-chain integrity.
  • The designation acknowledges that inclusion on the list does not automatically signify a government's failure, considering geographic and economic factors.

Who covered it

Left 17%(1)Centre 0%(0)Right 83%(5)

Percentages are shares of the 6 outlets carrying a published leaning rating. 13 of the 19 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

86/100

Craft

95/100

Hype

28/100

19 sources · methodology

Missing from the left

Only 1 of the 6 outlets with a published leaning rating that ran this story are rated left.

A reader who follows the left would not have seen this. We report the absence rather than explain it: outlets choose what to cover for many reasons, and we have no evidence about which one applies here.

The United States has designated India, China, and Pakistan as major drug transit or illicit drug-producing countries for fiscal year 2027. This presidential determination, submitted to Congress, identifies a total of 23 nations. The list also separately identifies Afghanistan, Bolivia, Burma, and Colombia as countries that have failed demonstrably to meet their counternarcotics obligations over the past year.

The determination specifies that appearing on the list does not automatically mean a government is failing to combat drug trafficking. Geographic, commercial, and economic factors that allow drugs or precursor chemicals to be produced or transported through a country's territory are considered. The US statement welcomed Prime Minister Narendra Modi's efforts to address illicit opium poppy cultivation and strengthen supply-chain integrity, expressing anticipation for continued cooperation through the US-India Drug Policy Framework.

Disagreement on Venezuela's status

TRT World reports that Venezuela was removed from the list of states designated as having "failed demonstrably" to adhere to counter-narcotics agreements. The other reports do not mention Venezuela's status on this specific list.

What the coverage left out

None of the right-rated digests mention the specific detail that the US determination welcomes Prime Minister Narendra Modi's efforts to address illicit opium poppy cultivation and strengthen supply-chain integrity, a fact noted by the left and centre reports.

Coverage settled. We checked this 9 times and stopped on 22 Sept 2026, 03:45. The figures above are what it finished at.

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

1 rated outlet

  • The left-rated digests focused on President Trump's criticism of Canada regarding drug control. All 12 digests noted that Canada was not included on the list of major drug-producing countries.
  • These reports stated that Trump accused Canada of not doing enough to stop drugs. The digests did not mention India, China, or Pakistan by name.
  • None of the left-rated digests quoted any officials or named any specific drugs. The reports did not include details on the criteria for the list or the consequences for countries named.

Centre

0 rated outlets

  • Live Mint and The Economic Times, the centre-rated reports, both focused on the US designation of India, China, and Pakistan as major drug transit or illicit drug-producing countries for FY2027. They noted that Afghanistan, Bolivia, Burma, and Colombia were identified for failing counternarcotics obligations. Live Mint's full report also detailed China's role in supplying precursor chemicals for synthetic drugs and welcomed India's efforts, while The Economic Times digest mentioned that inclusion on the list considers geographic and economic factors.

Right

5 rated outlets

  • The right-rated reports from NDTV, India Today, Times of India, and TRT World all highlighted President Trump's praise for Prime Minister Modi's opium crackdown. India Today specifically mentioned Trump urging China to tighten controls on drug precursor chemicals. NDTV and India Today's digests focused on Trump's claims of "historic progress" in tackling drug trafficking. The Times of India and TRT World digests noted the designation of India, China, and Pakistan among 23 countries, with TRT World also mentioning Venezuela's removal from a separate list.

Questions about this coverage

How did the left and right cover US names India, China, Pakistan on drug transit and production list?
Of the 6 outlets on this story carrying a published leaning rating, 17% are rated left, 0% are rated centre, 83% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 19. The sections above set out what each side emphasised, in its own terms.
Is US names India, China, Pakistan on drug transit and production list left or right?
Too few of the outlets on this story carry a published leaning rating to say. 6 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.
Is the coverage of US names India, China, Pakistan on drug transit and production list biased?
US names India, China, Pakistan on drug transit and production list is one event reported by 19 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which side is not reporting US names India, China, Pakistan on drug transit and production list?
When we first saw this story, outlets rated left had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.
Which outlets covered US names India, China, Pakistan on drug transit and production list?
19 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
Which countries were named in the US determination for fiscal year 2027?
The US presidential determination for fiscal year 2027 named India, China, and Pakistan among 23 countries designated as major drug transit or illicit drug-producing nations. Additionally, Afghanistan, Bolivia, Burma, and Colombia were identified as countries that have failed demonstrably to meet counternarcotics obligations.
Does being on the US drug list mean a country is failing to combat drug trafficking?
No, the US determination makes clear that inclusion on the list does not automatically signify a government's failure. Geographic, commercial, and economic factors that facilitate drug production or transport through a country's territory are also considered in the designation.
What did the US say about India's efforts?
The US statement welcomed Prime Minister Narendra Modi and the Indian government's efforts to address illicit opium poppy cultivation and strengthen supply-chain integrity. Washington also stated it looks forward to continued cooperation with India through the US-India Drug Policy Framework.

Read it at the source

64 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

19
Show 11 more

Centre

17
Show 9 more

Right

9
Show 1 more

Not rated

19
Show 11 more

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

US Drug Transit Countries List | MediaBias News